Works matching IS 15228517 AND DT 2017 AND VI 19 AND IP 6
Results: 16
Corrigenda.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 876, doi. 10.1093/neuonc/nox045
- Publication type:
- Article
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab--a report from the BELOB trial.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 853, doi. 10.1093/neuonc/now311
- By:
- Publication type:
- Article
MEK and RAF inhibitors: time for a paradigm shift in the treatment of pediatric low-grade gliomas?
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 741, doi. 10.1093/neuonc/nox039
- By:
- Publication type:
- Article
Response assessment in high-grade glioma: tumor volume as endpoint.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 744, doi. 10.1093/neuonc/nox035
- By:
- Publication type:
- Article
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 845, doi. 10.1093/neuonc/nox020
- By:
- Publication type:
- Article
Letters to the Editor.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 871
- By:
- Publication type:
- Article
Sex as a biological variable in response to temozolomide.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 873, doi. 10.1093/neuonc/nox040
- By:
- Publication type:
- Article
Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 796, doi. 10.1093/neuonc/now287
- By:
- Publication type:
- Article
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 786, doi. 10.1093/neuonc/now285
- By:
- Publication type:
- Article
Integrated genomic analysis of survival outliers in glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 833, doi. 10.1093/neuonc/now269
- By:
- Publication type:
- Article
Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 808, doi. 10.1093/neuonc/now267
- By:
- Publication type:
- Article
MRI features predict survival and molecular markers in diffuse lower-grade gliomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 862, doi. 10.1093/neuonc/now256
- By:
- Publication type:
- Article
Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 820, doi. 10.1093/neuonc/now253
- By:
- Publication type:
- Article
Pediatric low-grade gliomas: implications of the biologic era.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 750, doi. 10.1093/neuonc/now209
- By:
- Publication type:
- Article
Management of hormone-secreting pituitary adenomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 762, doi. 10.1093/neuonc/now130
- By:
- Publication type:
- Article
A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 774, doi. 10.1093/neuonc/now261
- By:
- Publication type:
- Article